Michael Schwaninger

News Release

7.10.2025

Merz Therapeutics Expands Presence with New Affiliate in...

Merz Therapeutics GmbH, a leading player in neurology-focused specialty pharma, today announced the opening of its new affiliate in Warsaw, Poland....

News Release

25.08.2025

Merz Therapeutics Announces First Patients Enrolled in Two...

Merz Therapeutics GmbH, a leading player in neurology-focused specialty pharma, today announced that the first patients have been enrolled in two...

Platform change – You are leaving this page.

You are leaving this website. With respect to the content of the following page, as well as to links to other websites located on this page, Merz Therapeutics GmbH has no way of controlling the content of these sites. Merz Therapeutics GmbH assumes no responsibility for the content of these sites or the consequences of their use by visitors. However, we ask you to notify us immediately of any illegal content on the linked sites.

Change of country – You are leaving this page.

You are leaving this website. The content of the following sites maintained by the parent company or another affiliated company, or links to other sites located on this site, is subject to the legal requirements of the country in which the site is maintained. Merz Therapeutics GmbH accepts no responsibility whatsoever for the content of these websites or for the consequences of their use by visitors. However, we ask you to notify us immediately of any illegal content on the linked sites.

Michael Schwaninger

Related articles

Platform change – You are leaving this page.

Change of country – You are leaving this page.